XIIDERI
LIVE

Serial Number

79284838

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Mar 16, 2020

Add to watchlist:

No watchlists yet
View on USPTO

XIIDERI Trademark

Serial Number: 79284838 • Registration: 6192258

XIIDERI is a trademark filed by NOVARTIS AG on March 16, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

BAUSCH + LOMB IRELAND LIMITED (157 trademarks)

3013 LAKE DRIVE
DUBLIN 24 , IE

Entity Type: 77

Trademark Details

Filing Date

March 16, 2020

Registration Date

November 10, 2020

Published for Opposition

June 30, 2020

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the foregoing excluding pharmaceutical preparations for the treatment or prevention of neurological disorders, sleep disorders, and central nervous system

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 10, 2025 REM3
CHANGE OF OWNER RECEIVED FROM IB
May 10, 2024 CHLD
NOTIFICATION PROCESSED BY IB
Jan 8, 2021 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Dec 18, 2020 FICS
FINAL DISPOSITION PROCESSED
Dec 17, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Dec 10, 2020 GPAR
REGISTERED-PRINCIPAL REGISTER
Nov 10, 2020 R.PR
POST PUBLICATION AMENDMENT - ENTERED
Oct 8, 2020 CHPB
ASSIGNED TO PETITION STAFF
Oct 6, 2020 APET
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Sep 9, 2020 ETOP
TEAS POST PUBLICATION AMENDMENT RECEIVED
Aug 18, 2020 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 30, 2020 ETOF
PUBLISHED FOR OPPOSITION
Jun 30, 2020 PUBO
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 29, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 29, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 29, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 29, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 29, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 29, 2020 COAR
NOTICE OF PUBLICATION
Jun 10, 2020 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 28, 2020 CNSA
ASSIGNED TO EXAMINER
May 27, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
May 22, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 18, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 14, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 7, 2020 REPR